Philadelphia chromosome-positive chronic myeloid leukemia expressing p190BCR-ABL

Internal Medicine

Volumn 41, Issue 12, 2002, Pages 1183-1187

  Ohsaka, Akimichi ^a   Shiina, Shigeo ^b   Kobayashi, Masaru ^c   Kudo, Hideyuki ^c   Kawaguchi, Ryuji ^b  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Hitachi   (Japan)

^c SRL INC   (Japan)

Author keywords

Acute lymphoblastic leukemia; Chronic myelomonocytic leukemia; e1a2 transcript; Minor breakpoint cluster region

Indexed keywords

BCR ABL PROTEIN; HYDROXYUREA;

ADENOCARCINOMA; AGED; AMINO ACID SEQUENCE; ARTICLE; BONE MARROW CELL; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; EXON; GENETIC TRANSCRIPTION; HEMATOLOGICAL PARAMETERS; HUMAN; LUNG CANCER; MALE; MEDICAL LITERATURE; MONOCYTOSIS; PHENOTYPE; PHILADELPHIA 1 CHROMOSOME; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SKIN METASTASIS;

EID: 0036967725     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.41.1183     Document Type: Article

References (23)

1. Thijsen SFT, Schuurhuis GJ, van Oostveen JW, Ossenkoppele G.J. Chronic myeloid leukemia from basics to bedside. Leukemia 13: 1646-1674, 1999.
2. Melo JV. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 88: 2375-2384, 1996.
3. Pane F, Frigeri F, Sindona M, et al. Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction). Blood 88: 2410-2414, 1996.
4. Selleri L, von Lindern M, Hermans A, Meijer D, Torelli G, Grosveld G. Chronic myeloid leukemia may be associated with several bcr-abl transcripts including the acute lymphoid leukemia-type 7 kb transcript. Blood 75: 1146-1153, 1990.
5. Zaccaria A, Tassinari A, Testoni N, et al. Alternative BCR/ABL transcripts in chronic myeloid leukemia. Blood 76: 1663-1665, 1990.
6. Nakamura Y, Hirosawa S, Aoki N. Consistent involvement of the 3' half part of the first BCR intron in adult Philadelphia-positive leukaemia with-out M-bcr rearrangement. Br J Haematol 83: 53-57, 1993.
7. Guo JQ, Hirsch-Ginsberg CF, Xian YM, et al. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia. Hematol Pathol 7: 91-106, 1993.
8. BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia? Leukemia 8: 208-211, 1994.
9. Kunieda Y, Okabe M, Kurosawa M, Itaya T, Kakinuma M, Miyazaki T. Chronic myeloid leukemia presenting ALL-type BCR/ABL transcript. Ann Hematol 69: 189-193, 1994.
10. Costello RT, Gabert J, Brunel V, et al. Minor breakpoint cluster region (m-BCR) positive chronic myeloid leukaemia with an acute lymphoblastic leukaemia onset: a case report. Br J Haematol 91: 428-430, 1995.
11. Kirk JA, Radich J, Edmands S, et al. Unusual expression of mRNA typical of Philadelphia positive acute lymphoblastic leukemia detected in chronic myeloid leukemia. Am J Hematol 52: 129-134, 1996.
12. Yamaguchi H, Inokuchi K, Shinohara T, Dan K. Extramedullary presentation of chronic myelogenous leukemia with p190 BCR/ABL transcripts. Cancer Genet Cytogenet 102: 74-77, 1998.
13. Ohno T, Hada S, Sugiyama T, Mizumoto T, Furukawa H, Nagai K. Chronic myeloid leukemia with minor-bcr breakpoint developed hybrid type of blast crisis. Am J Hematol 57: 320-325, 1998.
14. Solves P, Bolufer P, Lopez JA, et al. Chronic myeloid leukemia with expression of ALL-type BCR/ABL transcript: a case-report and review of the literature. Leuk Res 23: 851-854, 1999.
15. BCR/ABL expression: characteristics and clinical significance. Br J Haematol 107: 581-586, 1999.
16. Roumier C, Daudignon A, Soenen V, et al. p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders? Haematologica 84: 1075-1080, 1999.
17. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51: 189-199, 1982.
18. Kantarjian HM, Kurzrock R, Talpaz M. Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia. Hematol Oncol Clin North Am 4: 389-404, 1990.
19. McLaughlin J, Chianese E, Witte ON. Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells. Mol Cell Biol 9: 1866-1874, 1989.
20. van Rhee F, Hochhaus A, Lin F, Melo JV, Goldman JM, Cross NCP. p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias. Blood 87: 5213-5217, 1996.
21. Saglio G, Pane F, Martinelli G, Guerrasio A. BCR/ABL transcripts and leukemia phenotype: an unsolved puzzle. Leuk Lymphoma 26: 281-286, 1997.
22. Li S, Ilaria RL Jr, Million RP, Daley GQ, Van Etten RA. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J Exp Med 189: 1399-1412, 1999.
23. Nagura E, Kawashima K, Yamada K. Multiple primary cancers associated with hematological malignancies. Jpn J Clin Oncol 15 Suppl 1: 211-222, 1985.